HIGHLIGHTS
- who: Bruce J. Brew from the Research, Sydney, NSW, Australia, Faculty of Medicine, St Vincent's Clinical School, University of New South Wales, Sydney have published the Article: Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis, in the Journal: (JOURNAL) of 30/01/2016
- what: In this review, the authors focus on evidence accumulated from MS studies that have demonstrated a dysregulation of the KP, resulting in elevated levels of neurotoxic metabolites both in the plasma and brain parenchyma (detected in CSF), and thus contribute to the progression . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.